Stay updated on 89Zr-Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the 89Zr-Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the 89Zr-Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government-operating-status notice; the previous v3.1.0 reference has been removed.
    Difference
    3%
    Check dated 2025-10-06T06:34:05.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Upgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:11:30.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' navigation element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:55:41.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T16:52:22.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location details, while key drug information related to pembrolizumab has been removed.
    Difference
    4%
    Check dated 2025-08-31T12:07:38.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:32:12.000Z thumbnail image

Stay in the know with updates to 89Zr-Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the 89Zr-Pembrolizumab in NSCLC Clinical Trial page.